Health economic implications of irbesartan treatment versus standard blood pressure control in patients with type 2 diabetes, hypertension and renal disease: a Hungarian analysis

By Palmer Andrew   Valentine William   Ray Joshua   Roze Stephane   Muszbek Noemi  

The European Journal of Health Economics, Vol. 8, Iss. 2, 2007-06 ,pp. : 161-168

Springer Publishing Company

Access to resources Recommend Favorite

Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes

By Palmer Andrew J.   Dinneen Sean   Gavin James R.   Gray Alastair   Herman William H.   Karter Andrew J.  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 861-872

Informa Healthcare

Access to resources Recommend Favorite

Acarbose treatment affects the serum levels of inflammatory cytokines and the gut content of bifidobacteria in Chinese patients with type 2 diabetes mellitus 阿卡波糖对中国2型糖尿病患者炎症因子及粪便双歧杆菌水平的作用

By  

JOURNAL OF DIABETES, Vol. 7, Iss. 5, 2015-09 ,pp. : 729-739

John Wiley & Sons Inc

Access to resources Recommend Favorite

Attenuation of Postprandial Hypotension with Acarbose in Older Adults with Type 2 Diabetes Mellitus

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 7, 2015-07 ,pp. : 1484-1486

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo‐Controlled Trial

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 11, 2015-11 ,pp. : 983-990

John Wiley & Sons Inc

Access to resources Recommend Favorite